Chronic constipation is one of the most common functional gastrointestinal disorders, with an estimated prevalence in North America of 2–27%. 1 Women, nonwhite people and elderly individuals are ...
In those not responding to conservative treatment, the approach needs to be tailored addressing all comorbid conditions. In the adult population, the management of constipation continues to evolve ...
Constipation is common in postmenopausal women. It may result from ... If your constipation becomes chronic, does not respond to at-home treatment, or is accompanied by the symptoms above ...
Diet and exercise changes, fiber supplements, and the occasional use of laxatives may ease constipation in most cases. However, with chronic constipation, it’s important to talk with a ...
Dr. Reddy’s Laboratories Ltd. on Monday announced the launch of Elobixibat, a first-in-class drug to treat chronic constipation, in India. According to the company’s statement, Dr. Reddy’s ...
Elobixibat is a breakthrough drug approved for the treatment of chronic constipation, it said adding that “It acts by inhibiting the reabsorption of bile acids from ileum, thus increasing their ...
Also read:Dr. Reddy’s R&D centre in Hyderabad completes US FDA inspection A breakthrough drug approved for treatment of chronic constipation, Elobixibat acts by inhibiting the reabsorption of ...
Research also suggests that chronic constipation, or constipation not ... She’s covered nutrition, women’s and children’s wellness issues, as well as specialized topics ranging from diabetes ...
A 2021 observational survey examined constipation prevalence among 474 pregnant women, 403 people in the postpartum period, and a control group of 200 women who were not pregnant and had not given ...